JB Chemicals & Pharmaceuticals Q2 Results Live : JB Chemicals & Pharmaceuticals has announced its Q2 results for the fiscal year, revealing a notable increase in profits and revenue. The company declared its financial performance on November 6, 2024, showing a year-over-year revenue growth of 13.48% and a profit increase of 15.92%. However, compared to the previous quarter, the revenue saw a slight decline of 0.38%, and profit decreased by 1.28%.
The company’s selling, general, and administrative expenses increased by 2.19% quarter-over-quarter and rose significantly by 15.03% year-over-year. This uptick in expenses has contributed to a decrease in operating income, which was down by 4.57% compared to the last quarter, although it still reflects an increase of 8.17% year-over-year.
Earnings per share (EPS) for the quarter stood at ₹11, marking a year-over-year increase of 15.3%. Despite the mixed results, JB Chemicals & Pharmaceuticals has shown resilience, with a -0.1% return in the last week, a 4.57% return over the past six months, and a robust 15.76% year-to-date return.
Currently, JB Chemicals & Pharmaceuticals boasts a market capitalization of ₹29,209.98 crore, with a 52-week high of ₹2030 and a low of ₹1371. The stock’s performance has attracted attention from analysts, with 1 analyst giving a Strong Sell rating, 2 analysts recommending a Hold, 2 advising a Buy, and 6 providing a Strong Buy rating.
As of November 7, 2024, the consensus recommendation among analysts is to Buy, indicating a positive outlook for the company’s future performance.
JB Chemicals & Pharmaceuticals Financials
| Period | Q2 | Q1 | Q-o-Q Growth | Q2 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 1000.62 | 1004.4 | -0.38% | 881.74 | +13.48% |
| Selling/ General/ Admin Expenses Total | 170.57 | 166.91 | +2.19% | 148.28 | +15.03% |
| Depreciation/ Amortization | 41.88 | 40.78 | +2.7% | 32.17 | +30.18% |
| Total Operating Expense | 771.98 | 764.81 | +0.94% | 670.37 | +15.16% |
| Operating Income | 228.64 | 239.59 | -4.57% | 211.37 | +8.17% |
| Net Income Before Taxes | 236.53 | 239.84 | -1.38% | 208.66 | +13.36% |
| Net Income | 174.57 | 176.83 | -1.28% | 150.59 | +15.92% |
| Diluted Normalized EPS | 11 | 11.16 | -1.43% | 9.54 | +15.3% |
#Chemicals #Pharmaceuticals #Results #Live #Profit #Rise #YOY #Company #Business #News
JB Chemicals & Pharmaceuticals Q2 result, JB Chemicals & Pharmaceuticals, JB Chemicals & Pharmaceuticals Q2, JB Chemicals & Pharmaceuticals Quarterly Result, Q2 Result
latest news today, news today, breaking news, latest news today, english news, internet news, top news, oxbig, oxbig news, oxbig news network, oxbig news today, news by oxbig, oxbig media, oxbig network, oxbig news media
HINDI NEWS
